Association of smoking and concomitant use of metformin with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes

ConclusionsIn type 2 diabetes patients, concurrent treatment with metformin attenuates the observed higher cardiovascular and mortality risk in ex‐ and current smokers. In addition to smoking cessation support, treatment with metformin, particularly in ex‐ and current smokers, should be encouraged.

Source: Journal of Diabetes - April 30, 2015 Category: Endocrinology Authors: Sanjoy K. Paul, Kerenaftali Klein, Azeem Majeed, Kamlesh Khunti Tags: Original Article Source Type: research